|
Powered by Cell Signaling Technology |
Site Information |
---|
GNSKSPKkGLktPkT SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 9905197 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on WSTF: | |
Effects of modification on biological processes: | |
Induce interaction with: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Liu Y, et al. (2020) WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. Oncogene 39, 5056-5067
32518374 Curated Info |
|
Choudhary C, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-40
19608861 Curated Info |
|
Rikova K (2008) CST Curation Set: 5646; Year: 2008; Biosample/Treatment: cell line, NCI-H2228/DMSO; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Antibodies Used to Purify Peptides prior to LCMS: Acetylated-Lysine (Ac-K2-100) Rabbit mAb Cat#: 9814, PTMScan(R) Acetyl-Lys Motif (Ac-K) Immunoaffinity Beads Cat#: 1989
Curated Info |